| Selective use of sorafenib in the treatment of thyroid cancer F Pitoia, F Jerkovich Drug design, development and therapy, 1119-1131, 2016 | 77 | 2016 |
| Dynamic risk assessment in patients with differentiated thyroid cancer F Pitoia, F Jerkovich Endocrine-Related Cancer 26 (10), R553-R566, 2019 | 54 | 2019 |
| Implementing the modified 2009 American Thyroid Association risk stratification system in thyroid cancer patients with low and intermediate risk of recurrence F Pitoia, F Jerkovich, C Urciuoli, A Schmidt, E Abelleira, F Bueno, G Cross, ... Thyroid 25 (11), 1235-1242, 2015 | 54 | 2015 |
| Burden of disease in patients with tumor induced osteomalacia F Jerkovich, S Nuñez, Y Mocarbel, A Pignatta, N Elías, H Cassinelli, ... Journal of Bone and Mineral Research Plus 5 (2), e10436, 2021 | 22 | 2021 |
| Real-life use of lenvatinib in patients with differentiated thyroid cancer: experience from Argentina F Jerkovich, I Califano, F Bueno, JM Carrera, R Giglio, E Abelleira, ... Endocrine 69, 142-148, 2020 | 22 | 2020 |
| Impaired bone microarchitecture and strength in patients with tumor‐induced osteomalacia MB Zanchetta, F Jerkovich, S Nuñez, Y Mocarbel, A Pignatta, N Elías, ... Journal of Bone and Mineral Research 36 (8), 1502-1509, 2020 | 21 | 2020 |
| Active surveillance of small metastatic lymph nodes as an alternative to Surgery in selected patients with low-risk papillary thyroid Cancer: a retrospective cohort study F Jerkovich, E Abelleira, F Bueno, L Guerrero, F Pitoia Thyroid 32 (10), 1178-1183, 2022 | 18 | 2022 |
| The experience of an Endocrinology Division on the use of tyrosine multikinase inhibitor therapy in patients with radioiodine-resistant differentiated thyroid cancer F Jerkovich, MG García Falcone, F Pitoia Endocrine 64, 632-638, 2019 | 17 | 2019 |
| Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease I Califano, A Smulever, F Jerkovich, F Pitoia Reviews in Endocrine and Metabolic Disorders 25 (1), 123-147, 2024 | 16 | 2024 |
| New approaches for patients with advanced radioiodine-refractory thyroid cancer F Pitoia, F Jerkovich, P Trimboli, A Smulever World Journal of Clinical Oncology 13 (1), 9, 2022 | 15 | 2022 |
| Should age at diagnosis be included as an additional variable in the risk of recurrence classification system in patients with differentiated thyroid cancer F Pitoia, F Jerkovich, A Smulever, G Brenta, F Bueno, G Cross European thyroid journal 6 (3), 160-166, 2017 | 14 | 2017 |
| Prevalencia de tiroideopatías en pacientes con diabetes tipo 2 F Jerkovich, D Moncet, JA Remón, G Isaac Revista argentina de endocrinología y metabolismo 51 (3), 123-129, 2014 | 9 | 2014 |
| Prevalence of thyroid disease in patients with type 2 diabetes F Jerkovich, D Moncet, J Remón, G Isaac Rev Argent Endocrinol Metab [Internet] 51 (3), 2016 | 8 | 2016 |
| Asymptomatic elevated parathyroid hormone level due to immunoassay interference MB Zanchetta, E Giacoia, F Jerkovich, E Fradinger Osteoporosis International 32 (10), 2111-2114, 2021 | 7 | 2021 |
| Osteomalacia oncogénica: Presentación de dos casos F Jerkovich MEDICINA (Buenos Aires) 75 (1), 37-40, 2015 | 7 | 2015 |
| Partial response to sorafenib treatment associated with transient grade 3 thrombocytopenia in a patient with locally advanced thyroid cancer F Pitoia, E Abelleira, F Jerkovich, C Urciuoli, G Cross Archives of Endocrinology and Metabolism 59, 347-350, 2015 | 7 | 2015 |
| Dynamic risk allows us to adequately select patients with differentiated thyroid cancer who do not require radioiodine treatment E Abelleira, MA Peñaloza, F Jerkovich, F Bueno, F Pitoia Archives of endocrinology and metabolism 65 (3), 315-321, 2021 | 6 | 2021 |
| Dynamic risk assessment in patients with differentiated thyroid cancer E Abelleira, F Jerkovich Reviews in Endocrine and Metabolic Disorders 25 (1), 79-93, 2024 | 5 | 2024 |
| Impact of historic histopathologic sample review on the risk of recurrence in patients with differentiated thyroid cancer F Pitoia, F Jerkovich, C Urciuoli, F Falcón, AP Lima Archives of Endocrinology and Metabolism 62, 157-163, 2018 | 5 | 2018 |
| “Foundation One™ Genomic Interrogation of Thyroid Cancers in Patients with Metastatic Disease Requiring Systemic Therapy” F Pitoia, A Smulever, F Jerkovich The Journal of Clinical Endocrinology & Metabolism 105 (9), e3490-e3491, 2020 | 4 | 2020 |
